FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

Novartis Pharmaceuticals Foradil Aerolizer Recall

Foradil Aerolizer (formoterol fumarate inhalation powder), 12 mcg per capsule, 60 Capsu…

Novartis Pharmaceuticals Corp. · Suffern, NY

Risk level
Class III
Reported by FDA
Jun 25, 2014
Recall ID
D-1387-2014
Check your lot numberHow we source this data

Summary

Novartis Pharmaceuticals recalled Foradil Aerolizer starting May 28, 2014. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-1387-2014 on Jun 25, 2014. Reason: Failed Stability Specification; out of specification result for particle size distribution during stability testing. Status: Terminated.

Why it was recalled

Failed Stability Specification; out of specification result for particle size distribution during stability testing

Product description

Foradil Aerolizer (formoterol fumarate inhalation powder), 12 mcg per capsule, 60 Capsules, Rx only, Manufactured for: Merck, Sharpe & Dohne Corp., a subsidiary of Merck & Co., Inc. Whitehouse Station, NJ 08889, Manufactured by: Novartis Pharma AG Basle, Switzerland NDC 0085-1401-01

Lot numbers, UPCs & expiration codes

Lot F0067 exp. 06/14, F0079 exp. 04/15

Where it was sold

Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1387-2014
Classification
Class III
Status
Terminated
Recall initiated
May 28, 2014
FDA report date
Jun 25, 2014
Quantity
Lot F0067: 45,834 units; Lot F0079: 63,321 units
Recall type
Voluntary: Firm initiated
Recalling firm
Novartis Pharmaceuticals Corp.

Original FDA data

Every field from FDA enforcement report D-1387-2014, exactly as published.

Show all FDA fields
City
Suffern
State
NY
Status
Terminated
Country
United States
Event ID
68282
Address
25 Old Mill Rd
Code information
Lot F0067 exp. 06/14, F0079 exp. 04/15
Postal code
10901-4106
Report date
Jun 25, 2014
Product type
Drugs
Recall number
D-1387-2014
Classification
Class III
Recalling firm
Novartis Pharmaceuticals Corp.
Product quantity
Lot F0067: 45,834 units; Lot F0079: 63,321 units
Termination date
Feb 12, 2015
Reason for recall
Failed Stability Specification; out of specification result for particle size distribution during stability testing
Voluntary / mandated
Voluntary: Firm initiated
Product description
Foradil Aerolizer (formoterol fumarate inhalation powder), 12 mcg per capsule, 60 Capsules, Rx only, Manufactured for: Merck, Sharpe & Dohne Corp., a subsidiary of Merck & Co., Inc. Whitehouse Station, NJ 08889, Manufactured by: Novartis Pharma AG Basle, Switzerland NDC 0085-1401-01
Distribution pattern
Nationwide
Recall initiation date
May 28, 2014
Initial firm notification
Letter
Center classification date
Jun 17, 2014

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1387-2014, published Jun 25, 2014. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls